Atjaunināt sīkdatņu piekrišanu

E-grāmata: Drug-delivery systems of phytochemicals as therapeutic strategies in cancer therapy

(CSIR-Central Food Technological Research Institute, Mysore, India), (Research Associate, Centre of Experimental Medicine and Surgery at Banaras Hindu University, India), (CSRTI)
  • Formāts: PDF+DRM
  • Izdošanas datums: 07-Nov-2023
  • Izdevniecība: Academic Press Inc
  • Valoda: eng
  • ISBN-13: 9780443159619
Citas grāmatas par šo tēmu:
  • Formāts - PDF+DRM
  • Cena: 176,20 €*
  • * ši ir gala cena, t.i., netiek piemērotas nekādas papildus atlaides
  • Ielikt grozā
  • Pievienot vēlmju sarakstam
  • Šī e-grāmata paredzēta tikai personīgai lietošanai. E-grāmatas nav iespējams atgriezt un nauda par iegādātajām e-grāmatām netiek atmaksāta.
  • Formāts: PDF+DRM
  • Izdošanas datums: 07-Nov-2023
  • Izdevniecība: Academic Press Inc
  • Valoda: eng
  • ISBN-13: 9780443159619
Citas grāmatas par šo tēmu:

DRM restrictions

  • Kopēšana (kopēt/ievietot):

    nav atļauts

  • Drukāšana:

    nav atļauts

  • Lietošana:

    Digitālo tiesību pārvaldība (Digital Rights Management (DRM))
    Izdevējs ir piegādājis šo grāmatu šifrētā veidā, kas nozīmē, ka jums ir jāinstalē bezmaksas programmatūra, lai to atbloķētu un lasītu. Lai lasītu šo e-grāmatu, jums ir jāizveido Adobe ID. Vairāk informācijas šeit. E-grāmatu var lasīt un lejupielādēt līdz 6 ierīcēm (vienam lietotājam ar vienu un to pašu Adobe ID).

    Nepieciešamā programmatūra
    Lai lasītu šo e-grāmatu mobilajā ierīcē (tālrunī vai planšetdatorā), jums būs jāinstalē šī bezmaksas lietotne: PocketBook Reader (iOS / Android)

    Lai lejupielādētu un lasītu šo e-grāmatu datorā vai Mac datorā, jums ir nepieciešamid Adobe Digital Editions (šī ir bezmaksas lietotne, kas īpaši izstrādāta e-grāmatām. Tā nav tas pats, kas Adobe Reader, kas, iespējams, jau ir jūsu datorā.)

    Jūs nevarat lasīt šo e-grāmatu, izmantojot Amazon Kindle.

Drug-delivery Systems of Phytochemicals as Therapeutic Strategies in Cancer Therapy elucidates the importance of various phytochemicals in cancer therapy and explains various routes/methods to deliver phytochemicals for overcoming the problems associated with delivery systems in cancer treatment. Several nanotechnological methods are presented to enhance drug solubility, sustainability, bioavailability, and gastrointestinal permeability of these phytochemicals. Current understanding of the relevant information presented on therapeutic strategies in cancer therapy fulfils the requirements of oncologists, molecular biologists, pharmacologist and related researchers who want to work in the areas of drug development targeting phytochemicals for cancer therapy.

1. Significance of phytochemicals in cancer therapy
2. Emerging need of delivery systems for plant metabolites
3. Phytosome: A promising drug-delivery system for cancer therapy
4. Exosome-based delivery systems for natural compounds in cancer therapy
5. Potential implications of ethosomes and transethosomes to deliver phytomedicine in cancer treatment
6. Chitosan-based drug delivery of plant metabolites for the treatment of breast cancer
7. Sporopollenin-based targeted drug delivery system for gastrointestinal cancer
8. Nanotechnology based delivery system for phytochemicals in cancer therapy
9. Delivery system of phenolic compounds for the treatment of lung cancer
10. Advancement in drug delivery systems of curcumin for cancer chemoprevention
11. Drug delivery system for saponins in cancer treatments
12. Administration of plant-derived terpenoids in cancer management
13. Therapeutic role of essential oils in malignancies through drug delivery mechanisms
14. Development of codelivery system for phytochemicals and targeted siRNA in cancer therapy
15. Future challenges of drug-delivery systems for phytochemicals in cancer management
Dr. Mamta Bisht is presently working as an Assistant Professor in Department of Chemistry, School of Applied and Life Sciences, Uttaranchal University (NAAC A+), Dehradun, Uttarakhand India. She is actively involved in the extraction, isolation, characterization of Natural Products” obtained from the medicinal and aromatic plants with bioactivity since last 8 years. Besides this her analytical skill is in GC, GC-MS, HPLC, Prep- HPLC and HPTLC. Further, she is equally involved in the promotion of endangered and economically important species from the Youngest Himalayan region. She has been published more than fifteen papers in peer-reviewed international journal and seven book chapter. Further, she has been participated more than ten conferences including national and international. She is life time member of Indian Science Congress Association. Under her guidance many P.G. and U.G. student successfully completed her Project Thesis and some students are working with her. She is also guided the Ph. D students in the University.

Divya Singh is presently working as Scientist-B in Department of Mulberry Physiology, CSRTI, Mysore, India. Her research specialization is primarily in genetics, proteomics, metabolomics, toxicology, bioinformatics and molecular biological evaluation in various in vivo and in vitro plant models to elucidate the physiological changes and evaluate the DNA damage potency. In her 11 years of research experiences, she has published 8-peer reviewed publications, two books (1 edited and 1 authored) including 6 book chapters and several meeting presentations at local and international scientific meetings. Dr. Rajesh Kumar Singh is currently working as a Research Associate in Banaras Hindu University. His research focus is pharmacognosy, reverse pharmacology, drug design and discovery, extraction & isolation of natural products, cell culture, and handling of different rodents. He has published several research articles in reputable journals over the course of his career. At present, he is involved in developing an Indian origin cell line and screening drugs of natural origin for the treatment of gallbladder cancer.